UNSPSC 85265904: Diagnosis of disorders of phosphorus metabolism and phosphatases

This classification denotes the group of activities that yields a diagnosis of Disorders of phosphorus metabolism and phosphatases. Disorders of phosphorus metabolism and phosphatases is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code E83. 3

UNSPSC 85265904 Diagnosis of disorders of phosphorus metabolism and phosphatases is a Commodity code that shows little relevant recent activity. The recent opportunities tagged under this code do not align with its nominal clinical laboratory diagnostic scope. San Mateo Medical Center's diagnostic imaging PACS solicitation concerns enterprise radiology and cardiology imaging system implementation rather than phosphorus metabolism testing; Birdville Independent School District's special education contracted services RFP addresses school-based therapist and evaluator staffing unrelated to the code; and the City of Orem's phosphorus control system is a wastewater treatment equipment procurement for struvite precipitation and nutrient removal, not clinical diagnostics. The Santa Clara Health System's temporary health professional staffing vehicle covers ancillary clinical categories including audiology, imaging, and therapy services but does not target phosphorus metabolism diagnosis specifically. None of the recent postings solicit laboratory reagents, testing kits, diagnostic assays, or clinical services for phosphorus disorder evaluation or phosphatase quantification.

State and local procurement activity under this code does not support a pursue recommendation at present. The mismatch between the code's clinical laboratory diagnostic intent and the actual work being solicited suggests either miscoding by issuing bodies or genuine absence of demand for phosphorus metabolism and phosphatase diagnostic services through state and local competitive procurement channels. Vendors with laboratory diagnostic or clinical chemistry capabilities should monitor for future activity but should not allocate business development resources to this code until opportunities appear that align with phosphorus metabolism testing, serum or urine phosphate assays, alkaline or acid phosphatase measurement, or related diagnostic imaging or analysis tied to phosphorus-metabolism disorders.